Ellevest Inc’s ARK Genomic Revolution ETF ARKG Stock Holding History

Ellevest Inc’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1	Closed	–	–	1123
2020 Q1	$0	Buy	+1	New	+$33	﹤0.01%	1079

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CFA

Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return

MCM

Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

CAN

Claraphi Advisory Network Aliso Viejo, United States $251M AUM 9.29% 1-Year Est. Return

LFA

Legend Financial Advisors Pittsburgh, Pennsylvania $176M AUM 57.06% 1-Year Est. Return

Ellevest Inc's ARKG Position: Q2 2020 in Review

Ellevest Inc sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2020, closing a stake of 1 share.

Ellevest Inc first reported a position in ARKG in Q1 2020 and held it in 1 quarter. The position peaked at $0 in Q1 2020. 168 funds tracked by Wall St. Rank hold ARKG as of Q2 2020.

Ellevest Inc reported no remaining ARK Genomic Revolution ETF position as of Q2 2020 after selling out during the quarter.
Ellevest Inc sold 1 ARK Genomic Revolution ETF share in Q2 2020.
Ellevest Inc first reported a position in ARK Genomic Revolution ETF in Q1 2020 and held it in 1 quarter.
Ellevest Inc's ARK Genomic Revolution ETF position peaked at $0 in Q1 2020.
168 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2020.

Based on Ellevest Inc's 13F filing for Q2 2020, filed 6 Jul 2020.